Mark & Associates, P.C. | Attorneys at Law

Live chat by Boldchat

By submitting this form I agree to the following disclaimer.

Helping People at Risk Due to Significant Asbestos Exposure

FDA Adds Liver Warning to Thyroid Drug

On June 3, 2009, the FDA advised physicians of the possible risk of serious liver injury with propylthiouracil, a drug prescribed to treat overactive thyroid glands or Graves' disease. Propylthiouracil is considered second-line treatment but is used when patients can't take another drug, methimazole. The FDA said it saw an increased ...